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Abstract 
The protein interacting with C-kinase 1 (PICK1) has been implicated in the 
susceptibility to schizophrenia. PICK1 interacts with enzymes and receptors that play 
roles in the pathogenesis of schizophrenia via glutamatergic dysfunction. Recently, two 
studies reported associations between schizophrenia and two PICK1 gene 
polymorphisms, rs3952 in Chinese and Japanese populations and rs2076369 in a 
Japanese population. We attempted to confirm these associations in a case-control study 
of 1765 Japanese patients with schizophrenia and 1851 Japanese control subjects. 
Neither polymorphism was associated with schizophrenia (rs3952, p = 0.755; 
rs2076369, p = 0.997). A haplotype block with these polymorphisms spanning the 5’ 
region of the PICK1 gene showed high linkage disequilibrium in the Japanese 
population (D’ = 0.98, r2 = 0.34); however, neither haplotype was significantly 
associated with schizophrenia. We conclude that the common haplotypes and 
polymorphisms of the PICK1 gene identified thus far are unlikely to contribute to 
genetic susceptibility to schizophrenia in the Japanese population.  
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1. Objective of the study 
The protein interacting with C-kinase 1 (PICK1) is also known as protein 
kinase C-alpha-binding protein (PRKCABP). PICK1 contains a PDZ domain and a 
conserved arfaptin homology (AH) domain. The PDZ domain of rat Pick1 interacts with 
splice variants of AMPA receptor subunits (Dev et al., 1999; Lu &Ziff, 2005; Sossa et 
al., 2006), and PICK1 appears to modulate synaptic transmission by regulating AMPA 
receptors in brain(Xia et al., 1999). AMPA receptors can improve cognitive function in 
patients with schizophrenia(Coyle et al., 2002). PICK1 also colocalizes and interacts 
with dopamine transporter (DAT) (Torres et al., 2001), and metabotropic glutamate 
receptor 7 (GRM7) (Boudin et al., 2000; Dev et al., 2001; Enz &Croci, 2003). More 
recently, Fujii et al. (2006) found that PICK1 interacts with serine racemase, which is a 
D-serine synthesizing enzyme that may play a role in the pathogenesis of schizophrenia. 
Taken together, the functional and structual features of PICK1 suggest that it may play a 
role in schizophrenia, because glutamatergic and dopaminergic dysfunction are thought 
to be involved in one of the most important neural pathways underlying vulnerability to 
the disease.  
In situ hybridization analysis revealed that PICK1 gene expression was 
decreased in dorsolateral prefrontal cortex (DLPFC) of patients with 
schizophrenia.(Beneyto &Meador-Woodruff, 2006) In contrast, Dracheva et al. (2005) 
could not find a significant change in PICK1 gene expression in DLPFC. Therefore 
evaluation of possible effects of antipsychotics on PICK1 expression or a transgenic 
animal study may be required to understand a role of the gene underlying schizophrenia.  
Despite inconclusive results, genetic studies have yielded evidence that PICK1 
plays a role as a susceptibility gene in schizophrenia. PICK1 contains 13 exons 
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spanning approximately 18 kb and is located on chromosome 22q12.13-q13.2, where 
linkages for schizophrenia have been suggested (Gill et al., 1996; Kalsi et al., 1995). 
Further, two case-control studies of single nucleotide polymorphisms (SNPs), rs3952 
and rs2076369 in PICK1 indicated an association between PICK1 and schizophrenia in 
Asian populations (Fujii et al., 2006; Hong et al., 2004). These SNPs are located in the 
5’ region (introns 3 and 4) of PICK1 with 7054 bp distance in one haplotype block that 
covers most PICK1 of the region both in Asian and European populations. There are 
less informative markers in the 3’ region of PICK1, according to the HapMap database 
(http://www.hapmap.org/). The haplotype block contains the region encoding the 
functionally important PDZ domain of PICK1. In addition, because the haplotype block 
might contain the promoter region of PICK1, the association may explain reported 
differences in PICK1 expression in schizophrenia (Beneyto &Meador-Woodruff, 2006).  
The previously reported association studies composed 400 Japanese and 485 
Chinese subjects. It should be noted that the minor allele of rs3952 was different one 
between those two populations. The NCBI database showed a similar genotype 
distribution of rs3952 in Japanese and European populations but provides no 
information for Chinese population. Larger population studies may solve a stratification 
problem in general Asian population. Because the most straightforward way to evaluate 
a genetic association is to perform analyses with sufficient statistical power to reveal the 
association, we attempted to confirm the association between PICK1 and schizophrenia 
in a large Japanese population in the present study.  
 
2. Materials and Methods 
2.1. Subjects 
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All subjects were of Japanese descent and were recruited from the main island 
of Japan. A total of 1765 unrelated patients with schizophrenia (mean age ± SD, 49.0 ± 
14.3 years; 944 men and 821 women) were diagnosed according to the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Control subjects 
were 1851 mentally healthy unrelated subjects (mean age ± SD, 48.9 ± 14.5 years; 1020 
men and 831 women) with no self-reported family history of mental illness within 
second-degree relatives. The present study was approved by the Ethics Committees of 
the University of Tsukuba, Niigata University, Fujita Health University, Nagoya 
University, Okayama University and Teikyo University, and all participants provided 
written informed consent. 
 
2.2. Genotyping 
DNA was extracted from blood samples. We genotyped two SNP markers, 
rs3952 in intron 3 and rs2076269 in intron 4, in PICK1. The SNPs were genotyped by 
TaqMan assay. Predesigned TaqMan SNP genotyping assays, C_2487464_10 for rs3952 
and C_2487476_10 for rs2076369, were selected from the Applied Biosystems database 
(http://www.appliedbiosystems.com). The TaqMan reaction was performed in a final 
volume of 3 μl consisting of 2.5 ng genomic DNA and Universal Master Mix 
(Eurogentic, Seraing, Belgium), and genotying was performed with an ABI PRISM 
7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA).  
 
2.3. Statistical analysis  
Hardy-Weinberg equilibrium, linkage disequilibrium and allelic/haplotype 
frequencies, as well as an association between SNP or haplotype and schizophrenia, 
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were evaluated with the Haploview software program 
(http://www.broad.mit.edu/mpg/haploview/). Permutation tests were also performed to 
calculate corrected p values for multiple testing with the Haploview software. 
Genotype-based association was tested with Cochran-Armitage test for trends. 
Statistical significance was accepted at p < 0.05.  
 
3. Results 
Genotypic/allelic distributions of the two PICK1 SNPs among the subject 
groups are shown in Table 1 and Table 2. Distributions of the rs3952 and rs2076369 
SNPs did not differ from Hardy-Weinberg equilibrium (p = 0.15 and 0.11, respectively). 
No genotype/allelic association with schizophrenia was detected for rs3952 (p = 0.54/p 
= 0.48 [corrected by multiple comparison: 0.76]), and rs2076369 (p = 0.91/p = 0.90 
[corrected by multiple comparison: 1.00]). With respect to schizophrenia subtype, no 
association was found between either population with organized or disorganized 
schizophrenia vs. controls (Table 3). These SNPs were in linkage disequilibrium from 
each other in both groups of controls (D’ = 0.98, r2 = 0.34) and of the patients (D’ = 
0.99, r2 = 0.34). Haplotype frequencies did not differ significantly between the 
schizophrenia and control groups (Table 4).  
 
4. Discussion 
The SNPs that have been reported to be associated with schizophrenia are 
included in one haplotype block that appears to have three major haplotypes in our 
Japanese population. A significant difference in the rs3952 genotype distribution 
between Japanese and Chinese populations have been observed repeatedly. However, 
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the haplotype block extends from the 5’ region towards most genetic region of the 
PICK1 gene in Japanese and Caucasian populations according to the HapMap database 
(http://www.hapmap.org/cgi-perl/gbrowse/hapmap_B35/), although there are less 
informative markers with informative minor allele frequencies in the 3’ region of PICK1. 
The results of the present study clearly exclude the 5’ region of the PICK1 gene as a 
factor contributing to susceptibility to schizophrenia. As noted, the haplotype block 
encodes the PDZ domain of PICK1, which interacts with several glutamatergic and 
dopaminergic molecules that have been suggested to play important roles in 
vulnerability to schizophrenia. Although only two markers were used in the present 
study, we could exclude the possibility genetic variation(s) in the 5’ flanking region of 
PICK1 involved in the strong LD haplotype block. However, because no study analyzed 
other markers in the PICK1 gene, there still be a possibility of involvement of the 3’ 
region of PICK1 in pathogenesis of schizophrenia. 
We calculated the power of our study on the basis of the genotype data. With a 
relative genetic risk of 1.2 and assuming an α value of 0.05 and a risk allele frequency 
of 0.4, the sample size of the present study had a power of 0.97. Therefore, the present 
data strongly indicate that an association between the rs3952 and rs2076369 and 
schizophrenia is not likely in the Japanese population. Although the Chinese patients 
with schizophrenia were limited of early 20s age-onset, general population of patients 
with schizophrenia has similar age-onset. Thus, age-onset distribution did not differ 
significantly between the present study and the previous of a Chinese population that 
reported an association between rs3952 and schizophrenia (Hong et al., 2004). 
One limitation of this study is that we could examine an association between 
generalized schizophrenia and PICK1, but the number of samples for specific types of 
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schizophrenia was limited (disorganized type, n = 233, Non-disorganized type, n = 217). 
Also, in a previous study of Japanese population, the association between the PICK1 
gene and schizophrenia was observed mainly for disorganized-type schizophrenia 
(rs3952, p = 0.05; rs2076369, p = 0.012; rs3952/rs2076369 haplotype, global p = 0.011, 
AT, p = 0.015, GG, p = 0.05), whereas no association was observed for organized-type 
schizophrenia (Fujii et al., 2006) (Tables 3 and 4). Because the minor allele frequency 
of the rs3952 SNP in our schizophrenic patients was similar to that of the total 
schizophrenic population in the previous study (Fujii et al., 2006), it is unlikely that 
most of our patients had organized-type schizophrenia. An observed difference in the 
allelic distribution of the rs2076369 SNP in schizophrenic patients between our subjects 
and those of Fujii et al. (2006) (Table 3) cannot be explained by a difference in the 
distribution of schizophrenia subtypes in these sample populations. In conclusion, the 
rs3952 and rs2076369 SNPs in the PICK1 gene do not appear to play major roles in 
vulnerability to schizophrenia.  
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Table 1. Distribution of the polymorphisms in the PICK1  gene.
SNP marker Controls Schizophrenics p  value
rs3952 AA AG GG AA AG GG
(n = 1850) 46.3% 42.0% 11.7% (n  = 1765) 44.6% 43.8% 11.6% 0.299
rs2076369 TT GT GG GG GA AA
(n = 1851) 18.0% 47.4% 34.5% (n  = 1765) 17.7% 47.4% 34.9% 0.748
Table 2. Minor allele frequency of the polymorphisms in the PICK1  gene.
SNP marker Controls Schizophrenics χ2 p  value
rs3952
Present study 32.7% (n = 1850) 33.9% (n  = 1765) 1.08 0.299
Hong et al. (2004) 42.5% (n  = 260) 35.3% (n  = 255) 5.20 0.025
Fujii et al. (2006) 36.2% (n  = 200) 32.0% (n  = 200) 1.61 0.493
rs2076369
Present study 41.8% (n  = 1851) 41.4% (n  = 1765) 0.10 0.748
Fujii et al. (2006) 38.2% (n  = 200) 46.2% (n  = 200) 5.25 0.080
* Minor allele is different in Chinese population according to Hong et al. (2004).
Table 3. Minor allele frequency of the polymorphisms in the PICK1 gene.
SNP marker Controls Schizophrenics
Disorganized Non-disorganized
rs3952
Present study 32.7% 32.8% 32.8%
(n = 1765) (n = 238) (n = 276)
χ2 0.001 0.002
p value 0.97 0.96
Fujii et al. (2006) 36.2% 26.1% 36.8%
(n = 200) (n = 90) (n = 110)
χ2 5.76 0.02
p value 0.05 1.00
rs2076369
Present study 41.8% 40.3% 41.5%
(n = 1765) (n = 237) (n = 277)
χ2 0.35 0.01
p value 0.55 0.93
Fujii et al. (2006) 38.2% 48.9% 42.3%
(n = 200) (n = 90) (n = 110)
χ2 8.42 0.96
p value 0.01 0.63
Table 3. Minor allele frequency of the polymorphisms in the PICK1 gene.
SNP marker Controls Schizophrenics
Disorganized Non-disorganized
rs3952
Present study 32.7% 32.8% 32.8%
(n = 1765) (n = 238) (n = 276)
χ2 0.001 0.002
p value 0.97 0.96
Fujii et al. (2006) 36.2% 26.1% 36.8%
(n = 200) (n = 90) (n = 110)
χ2 5.76 0.02
p value 0.05 1.00
rs2076369
Present study 41.8% 40.3% 41.5%
(n = 1765) (n = 237) (n = 277)
χ2 0.35 0.01
p value 0.55 0.93
Fujii et al. (2006) 38.2% 48.9% 42.3%
(n = 200) (n = 90) (n = 110)
χ2 8.42 0.96
p value 0.01 0.63
Table 4. Haplotype frequencies of the PICK1  gene
Present study Fujii et al. (2006)
Haplotype Control Schizophrenics χ2 p  value Control Schizophrenics χ2 p  value
AT 0.416 0.412 0.15 0.695 (0.932) 0.382 0.460 (0.511) 4.93 (8.42)0.062 (0.015)
GG 0.326 0.336 0.80 0.373 (0.650) NA NA NS
AG 0.257 0.250 0.41 0.523 (0.817) NA NA NS
Ηaplotype frequencies were compared between controls and schizophrenics; χ2 and nominal (corrected) p values are shown.
Numbers and numbers in parantheses for Fujii et al. (2006) indicate the haplotype frequency and statistics, respectively, in patients with disorganize
NS, not significant.
ed-type only.
